chr17-7196492-G-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001321075.3(DLG4):​c.1167C>T​(p.Ile389Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.305 in 1,613,368 control chromosomes in the GnomAD database, including 77,375 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6382 hom., cov: 32)
Exomes 𝑓: 0.31 ( 70993 hom. )

Consequence

DLG4
NM_001321075.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.74

Publications

50 publications found
Variant links:
Genes affected
DLG4 (HGNC:2903): (discs large MAGUK scaffold protein 4) This gene encodes a member of the membrane-associated guanylate kinase (MAGUK) family. It heteromultimerizes with another MAGUK protein, DLG2, and is recruited into NMDA receptor and potassium channel clusters. These two MAGUK proteins may interact at postsynaptic sites to form a multimeric scaffold for the clustering of receptors, ion channels, and associated signaling proteins. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
DLG4 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual developmental disorder 62
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 17-7196492-G-A is Benign according to our data. Variant chr17-7196492-G-A is described in ClinVar as Benign. ClinVar VariationId is 1255506.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.74 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.322 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DLG4NM_001321075.3 linkc.1167C>T p.Ile389Ile synonymous_variant Exon 10 of 20 ENST00000399506.9 NP_001308004.1 P78352-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DLG4ENST00000399506.9 linkc.1167C>T p.Ile389Ile synonymous_variant Exon 10 of 20 2 NM_001321075.3 ENSP00000382425.2 P78352-1
DLG4ENST00000648172.9 linkc.1296C>T p.Ile432Ile synonymous_variant Exon 12 of 22 ENSP00000497806.3 P78352-2
DLG4ENST00000648896.1 linkc.1266C>T p.Ile422Ile synonymous_variant Exon 10 of 20 ENSP00000497546.1 A0A3B3ISQ5
DLG4ENST00000649520.1 linkc.987C>T p.Ile329Ile synonymous_variant Exon 9 of 19 ENSP00000497647.1 B7Z647
DLG4ENST00000648263.1 linkc.987C>T p.Ile329Ile synonymous_variant Exon 8 of 14 ENSP00000498035.1 A0A3B3IU19
DLG4ENST00000491753.2 linkn.1296C>T non_coding_transcript_exon_variant Exon 12 of 21 2 ENSP00000467897.2 B7Z3U2

Frequencies

GnomAD3 genomes
AF:
0.281
AC:
42701
AN:
151992
Hom.:
6380
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.197
Gnomad AMI
AF:
0.291
Gnomad AMR
AF:
0.239
Gnomad ASJ
AF:
0.305
Gnomad EAS
AF:
0.311
Gnomad SAS
AF:
0.191
Gnomad FIN
AF:
0.394
Gnomad MID
AF:
0.332
Gnomad NFE
AF:
0.326
Gnomad OTH
AF:
0.300
GnomAD2 exomes
AF:
0.283
AC:
70531
AN:
249188
AF XY:
0.286
show subpopulations
Gnomad AFR exome
AF:
0.198
Gnomad AMR exome
AF:
0.154
Gnomad ASJ exome
AF:
0.307
Gnomad EAS exome
AF:
0.312
Gnomad FIN exome
AF:
0.402
Gnomad NFE exome
AF:
0.326
Gnomad OTH exome
AF:
0.300
GnomAD4 exome
AF:
0.307
AC:
449018
AN:
1461258
Hom.:
70993
Cov.:
39
AF XY:
0.306
AC XY:
222099
AN XY:
726908
show subpopulations
African (AFR)
AF:
0.193
AC:
6470
AN:
33476
American (AMR)
AF:
0.161
AC:
7213
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.309
AC:
8085
AN:
26130
East Asian (EAS)
AF:
0.289
AC:
11479
AN:
39696
South Asian (SAS)
AF:
0.201
AC:
17371
AN:
86250
European-Finnish (FIN)
AF:
0.394
AC:
21056
AN:
53390
Middle Eastern (MID)
AF:
0.309
AC:
1780
AN:
5766
European-Non Finnish (NFE)
AF:
0.322
AC:
357400
AN:
1111460
Other (OTH)
AF:
0.301
AC:
18164
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
17736
35472
53209
70945
88681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11390
22780
34170
45560
56950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.281
AC:
42707
AN:
152110
Hom.:
6382
Cov.:
32
AF XY:
0.281
AC XY:
20898
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.197
AC:
8181
AN:
41516
American (AMR)
AF:
0.239
AC:
3654
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.305
AC:
1060
AN:
3470
East Asian (EAS)
AF:
0.310
AC:
1603
AN:
5166
South Asian (SAS)
AF:
0.191
AC:
921
AN:
4822
European-Finnish (FIN)
AF:
0.394
AC:
4166
AN:
10570
Middle Eastern (MID)
AF:
0.330
AC:
97
AN:
294
European-Non Finnish (NFE)
AF:
0.326
AC:
22134
AN:
67968
Other (OTH)
AF:
0.296
AC:
626
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1575
3150
4724
6299
7874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
426
852
1278
1704
2130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.304
Hom.:
27526
Bravo
AF:
0.264
Asia WGS
AF:
0.211
AC:
735
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual developmental disorder 62 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

DLG4-related disorder Benign:1
Sep 24, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Benign
9.3
DANN
Benign
0.80
PhyloP100
-2.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17203281; hg19: chr17-7099811; COSMIC: COSV57236265; COSMIC: COSV57236265; API